Inter- and intraobserver consistency in assessing eligibility for bevacizumab (BVZ) in non-small-cell lung cancer (NSCLC) patients with centrally located tumors
Titel:
Inter- and intraobserver consistency in assessing eligibility for bevacizumab (BVZ) in non-small-cell lung cancer (NSCLC) patients with centrally located tumors
Auteur:
Barlési, F. Balleyguier, C. Besse, B. Bonodeau, F. Brenac, F. Corneloup, O. Dansin, E. Ferretti, G. Gaubert, J.Y. Gervais, R. Lacombe, C. Loundou, A. Moro-Sibilot, D. Planchard, D. Scherpereel, A. Menu, Y.